Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer
Redox Biology · 2024-07 · 73 · 103207
DOI: 10.1016/j.redox.2024.103207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2024-07. Verfasst von Shuohui Dong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Qilu Hospital of Shandong University, No. 107 Wenhua Xilu, Jinan, Shandong, 250012, China. Hauptthemen laut MEDLINE: Dihydroorotate Dehydrogenase, Fluorouracil, Colorectal Neoplasms, Mitochondria. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Although 5-fluorouracil (5-FU) is the primary chemotherapy treatment for colorectal cancer (CRC), its efficacy is limited by drug resistance. Ferroptosis activation is a promising treatment for 5-FU-resistant cancer cells; however, potential therapeutic targets remain elusive. This study investigated ferroptosis vulnerability and dihydroorotate dehydrogenase (DHODH) activity using stable, 5-FU-resistant CRC cell lines and xenograft models. Ferroptosis was characterized by measuring malondialdehyde levels, assessing lipid metabolism and peroxidation, and using mitochondrial imaging and assays. DHODH function is investigated through gene knockdown experiments, tumor behavior assays, mitochondrial import reactions, intramitochondrial localization, enzymatic activity analyses, and metabolomics assessments. Intracellular lipid accumulation and mitochondrial DHODH deficiency led to lipid peroxidation overload, weakening the defense system of 5-FU-resistant CRC cells against ferroptosis. DHODH, primarily located within the inner mitochondrial membrane, played a crucial role in driving intracellular pyrimidine biosynthesis and was redistributed to the cytosol in 5-FU-resistant CRC cells. Cytosolic DHODH, like its mitochondrial counterpart, exhibited dihydroorotate catalytic activity and participated in pyrimidine biosynthesis. This amplified intracellular pyrimidine pools, thereby impeding the efficacy of 5-FU treatment through molecular competition. These findings contribute to the understanding of 5-FU resistance mechanisms and suggest that ferroptosis and DHODH are promising therapeutic targets for patients with CRC exhibiting resistance to 5-FU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Qilu Hospital of Shandong University, No. 107 Wenhua Xilu, Jinan, Shandong, 250012, China.
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
- Department of General Surgery, Peking University People's Hospital, Beijing, 100044, China.
- Department of General Surgery, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University, Jinan, Shandong, 250014, China.
- Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong University, No. 4, Duanxing West Road, Jinan, Shandong,250022, China. Electronic address: shuol…
- Department of General Surgery, Qilu Hospital of Shandong University, No. 107 Wenhua Xilu, Jinan, Shandong, 250012, China. Electronic address: wkx3726@163.com.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Dong, S., Zhang, M., Cheng, Z., Zhang, X., Liang, W., Li, S., Li, L., Xu, Q., Song, S., Liu, Z., Yang, G., Zhao, X., Tao, Z., Liang, S., Wang, K., Zhang, G., & Hu, S. (2024). Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer. Redox Biology, 73, 103207. https://doi.org/10.1016/j.redox.2024.103207
Vancouver
Dong S, Zhang M, Cheng Z, Zhang X, Liang W, Li S, et al. Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer. Redox Biology. 2024;73:103207. doi:10.1016/j.redox.2024.103207
BibTeX
@article{Dong2024,
author = {Dong, Shuohui and Zhang, Mingguang and Cheng, Zhiqiang and Zhang, Xiang and Liang, Weili and Li, Songhan and Li, Linchuan and Xu, Qian and Song, Siyi and Liu, Zitian and Yang, Guangwei and Zhao, Xiang and Tao, Ze and Liang, Shuo and Wang, Kexin and Zhang, Guangyong and Hu, Sanyuan},
title = {Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer},
journal = {Redox Biology},
year = {2024},
volume = {73},
pages = {103207},
doi = {10.1016/j.redox.2024.103207}
}
EUVIMED